Companies need to establish that their water system is adequately designed, controlled, maintained and monitored to ensure that it is consistently producing water for its intended use.
A flood of warning letters from the FDA on water system suitability could pull the plug on the production of food, beverage, cosmetic, nutraceutical and over-the-counter (OTC) or pharmaceutical products if companies are not conducting total organic carbon (TOC) water testing analysis on a regular basis.
The FDA has made available testing results for PFAS in seafood samples collected at retail.
September 7, 2022
In a Constituent Update issued by the FDA, the agency has made available testing results for per- and polyfluoroalkyl substances (PFAS) in seafood samples collected at retail. The FDA conducted this limited survey as a preliminary step to determine if a more targeted or larger seafood survey should be conducted.
On August 11, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency's recent increased flexibilities.
This guidance document, which has been issued to increase the supply of infant formula, will remain in effect until November 14, 2022, at which time the FDA will evaluate whether any extension is necessary.
Estimated exposure PFOA from the samples of canned clams, which were from China, is likely a health concern
July 7, 2022
In a Constituent Update released today, the FDA has made available testing results for per- and polyfluoroalkyl substances (PFAS) in seafood samples collected at retail.